Article

Rheinmetall officially withdrew its alternative bid for Mynaric on March 11, undermining Germany's justification for blocking Rocket Lab's $150 million acquisition. Over 90% of Mynaric's backlog is linked to U.S.

Department of Defense funding, diminishing its status as a sovereign German asset. The German Ministry of Economic Affairs delayed the acquisition process, causing financial strain on Mynaric. Rheinmetall concluded it was more beneficial to acquire Mynaric's technology through commercial means rather than ownership. The German government is now faced with a decision to approve Rocket Lab's acquisition by the end of March, which could ensure Mynaric's operational stability and enhance Germany's role in European defense initiatives.